SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of NK.SET™. Developed using the Company's proprietary...
StockWatch: Data, Big Name Investors Drive Prime Medicine Stock Surge
Prime Medicine (NASDAQ: PRME) has had a lot to celebrate in recent months, explaining a surge that has seen the prime editing therapy developer’s stock more than double this year, including a 22% jump...
UC Davis wins NSF grants to advance AI-driven protein engineering
Two projects at the University of California, Davis, that use artificial intelligence to design and engineer proteins for industrial and health applications have been funded by the U.S. National Science Foundation (NSF). The grants...
Cellares and Technology Provider Team Plan to Expand Cell Q’s Capabilities for Commercial Scale...
Officials at Cellares say the Integrated Development and Manufacturing Organization (IDMO) entered multiple strategic technology partnerships to advance the Cell Q, a fully automated quality control testing platform purpose-built to match the commercial-scale throughput...
Clinical trial reveals encouraging results for apitegromab in spinal muscular atrophy
A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents with spinal muscular atrophy, according to a study published in The Lancet Neurology. Spinal muscular atrophy...
Streamlining Residual Host Cell Impurity Monitoring
Large molecule biotherapeutics are primarily expressed and produced in mammalian host cells then purified from complex mixtures containing growth media and host cell material. Identifying, monitoring, and eliminating host cell proteins (HCP) and host...
CRISPR-based tongue swab test shows promise for tuberculosis detection
Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, a potential breakthrough that could allow easier, community-based screenings for the world's deadliest infectious disease. Current TB...
Breakthrough in building functional synthetic kidneys using assembloids
A USC Stem Cell-led research team has achieved a major step forward in the effort to build mouse and human synthetic kidneys. In a new paper published in Cell Stem Cell, the scientists describe generating...
Enhanced Genomics extends Series A funding to USD $19 million to drive development of...
Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced it has completed a financing round, extending its total Series A funding...
Novartis Inks Up-to-$5.7B Second Collaboration with Monte Rosa
Nearly a year after licensing Monte Rosa Therapeutics’ Phase II-bound autoimmune disease candidate MRT-6160, Novartis has agreed to partner on developing additional molecular glue degraders (MGDs) for immune-mediated diseases, in an expanded collaboration that...
